173 related articles for article (PubMed ID: 33998094)
1. The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
Goshtasbi K; Abiri A; Lehrich BM; Haidar YM; Tjoa T; Kuan EC
Head Neck; 2021 Sep; 43(9):2755-2763. PubMed ID: 33998094
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
[TBL] [Abstract][Full Text] [Related]
3. Facility Volume and Survival in Nasopharyngeal Carcinoma.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Lee NY; Ho AS; Zumsteg ZS
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):408-417. PubMed ID: 29100787
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Facility Volume and Type on Skull Base Chordoma Treatment and Outcomes.
Du AT; Pang JC; Victor R; Tang Meller LL; Torabi SJ; Goshtasbi K; Kim MG; Hsu FPK; Kuan EC
World Neurosurg; 2022 Oct; 166():e561-e567. PubMed ID: 35868508
[TBL] [Abstract][Full Text] [Related]
6. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
[TBL] [Abstract][Full Text] [Related]
7. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Liu GY; Lv X; Wu YS; Mao MJ; Ye YF; Yu YH; Liang H; Yang J; Ke LR; Qiu WZ; Huang XJ; Li WZ; Guo X; Xiang YQ; Xia WX
Cancer Commun (Lond); 2018 May; 38(1):21. PubMed ID: 29764487
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy in local-regionally advanced nasopharyngeal carcinoma: A National Cancer Database analysis.
Tam M; Lee A; Wu SP; Gerber NK; Li Z; Givi B; Hu K; Schreiber D
Laryngoscope; 2018 Dec; 128(12):2770-2777. PubMed ID: 30133799
[TBL] [Abstract][Full Text] [Related]
9. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.
Sun J; Huang Z; Hu Z; Sun R
J Transl Med; 2017 May; 15(1):116. PubMed ID: 28558725
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and nasopharyngeal cancer.
Verma V; Simone CB; Lin C
Head Neck; 2018 Apr; 40(4):696-706. PubMed ID: 29323765
[TBL] [Abstract][Full Text] [Related]
11. Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study.
Liu DH; Zhou XY; Pan YG; Chen S; Ye ZH; Chen GD
Cancer Med; 2020 Feb; 9(4):1287-1297. PubMed ID: 31859464
[TBL] [Abstract][Full Text] [Related]
12. The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.
Huang Y; Chen W; Haque W; Verma V; Xing Y; Teh BS; Brian Butler E
Cancer Med; 2018 Apr; 7(4):1093-1101. PubMed ID: 29493889
[TBL] [Abstract][Full Text] [Related]
13. Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy.
Rusthoven CG; Lanning RM; Jones BL; Amini A; Koshy M; Sher DJ; Bowles DW; McDermott JD; Jimeno A; Karam SD
Radiother Oncol; 2017 Jul; 124(1):139-146. PubMed ID: 28433411
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
[TBL] [Abstract][Full Text] [Related]
16. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis.
Nong S; Pan X; Chen K; Li Y; Zhu X
Med Sci Monit; 2020 Jun; 26():e922244. PubMed ID: 32541642
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
Han JE; Yi SK; Wang S; Erman A; Bearelly S; Sindhu S; Robbins JR; Bauman J; Hsu CC
Head Neck; 2019 Dec; 41(12):4076-4087. PubMed ID: 31520512
[TBL] [Abstract][Full Text] [Related]
19. The impact of target dosimetry on patients' locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis.
Wang J; Qing G; Ou X; Hu W; Hu C; Zhang Z
Radiother Oncol; 2019 Dec; 141():67-71. PubMed ID: 31547944
[TBL] [Abstract][Full Text] [Related]
20. Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.
Sun XS; Liang YJ; Liu SL; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Tang LQ; Mai HQ
Cancer Res Treat; 2019 Oct; 51(4):1259-1268. PubMed ID: 30653745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
